Tirzepatide (40mg and 60mg)

Tirzepatide is an innovative medication, approved by health authorities, that stands out for its potent weight loss effect, currently being one of the most effective clinical options for the treatment of obesity and overweight in adults.

How tirzepatide promotes weight loss

Tirzepatide works by simultaneously stimulating GLP-1 and GIP hormone receptors, which are responsible for regulating satiety and appetite control. This dual action leads to a significant increase in satiety, reduction of food cravings, greater appetite control, and decreased calorie intake throughout the day. The result is a progressive and sustained body weight loss, with average reductions of 15% to 25% of the initial weight after around a year and a half of use, depending on the dose and patient profile.

Tirzepatide represents a new era in the treatment of obesity, offering unprecedented weight loss results with medication and improving quality of life for those seeking healthy and lasting weight reduction.

Superior efficacy among medications

In clinical studies, tirzepatide has proven to be more effective than other medications in the same class (such as semaglutide and liraglutide), resulting in weight loss numbers close to those observed after bariatric surgery. In some cases, more than a third of patients on the maximum dose managed to lose at least 25% of their initial body weight during 72 weeks of treatment.

Indication and safe use

Tirzepatide is indicated for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) associated with comorbidities such as hypertension, type 2 diabetes, or cardiovascular diseases. Treatment must be supervised by a physician, always in combination with a balanced diet and physical exercise, as part of a personalized weight loss plan. The use of tirzepatide requires a medical prescription and professional follow-up for dose adjustment and monitoring of effects.

Other health benefits

Besides weight loss, tirzepatide promotes metabolic improvements such as reduced blood pressure, improved cholesterol levels, lowered blood glucose, and increased insulin sensitivity. These effects help reduce cardiovascular risk and contribute to the remission of conditions like prediabetes and insulin resistance.

Tirzepatide (40mg and 60mg)

Tirzepatide is an innovative medication, approved by health authorities, that stands out for its potent weight loss effect, currently being one of the most effective clinical options for the treatment of obesity and overweight in adults.

How tirzepatide promotes weight loss

Tirzepatide works by simultaneously stimulating GLP-1 and GIP hormone receptors, which are responsible for regulating satiety and appetite control. This dual action leads to a significant increase in satiety, reduction of food cravings, greater appetite control, and decreased calorie intake throughout the day. The result is a progressive and sustained body weight loss, with average reductions of 15% to 25% of the initial weight after around a year and a half of use, depending on the dose and patient profile.

Tirzepatide represents a new era in the treatment of obesity, offering unprecedented weight loss results with medication and improving quality of life for those seeking healthy and lasting weight reduction.

Superior efficacy among medications

In clinical studies, tirzepatide has proven to be more effective than other medications in the same class (such as semaglutide and liraglutide), resulting in weight loss numbers close to those observed after bariatric surgery. In some cases, more than a third of patients on the maximum dose managed to lose at least 25% of their initial body weight during 72 weeks of treatment.

Indication and safe use

Tirzepatide is indicated for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) associated with comorbidities such as hypertension, type 2 diabetes, or cardiovascular diseases. Treatment must be supervised by a physician, always in combination with a balanced diet and physical exercise, as part of a personalized weight loss plan. The use of tirzepatide requires a medical prescription and professional follow-up for dose adjustment and monitoring of effects.

Other health benefits

Besides weight loss, tirzepatide promotes metabolic improvements such as reduced blood pressure, improved cholesterol levels, lowered blood glucose, and increased insulin sensitivity. These effects help reduce cardiovascular risk and contribute to the remission of conditions like prediabetes and insulin resistance.

Tirzepatide (40mg and 60mg)

Tirzepatide is an innovative medication, approved by health authorities, that stands out for its potent weight loss effect, currently being one of the most effective clinical options for the treatment of obesity and overweight in adults.

How tirzepatide promotes weight loss

Tirzepatide works by simultaneously stimulating GLP-1 and GIP hormone receptors, which are responsible for regulating satiety and appetite control. This dual action leads to a significant increase in satiety, reduction of food cravings, greater appetite control, and decreased calorie intake throughout the day. The result is a progressive and sustained body weight loss, with average reductions of 15% to 25% of the initial weight after around a year and a half of use, depending on the dose and patient profile.

Tirzepatide represents a new era in the treatment of obesity, offering unprecedented weight loss results with medication and improving quality of life for those seeking healthy and lasting weight reduction.

Superior efficacy among medications

In clinical studies, tirzepatide has proven to be more effective than other medications in the same class (such as semaglutide and liraglutide), resulting in weight loss numbers close to those observed after bariatric surgery. In some cases, more than a third of patients on the maximum dose managed to lose at least 25% of their initial body weight during 72 weeks of treatment.

Indication and safe use

Tirzepatide is indicated for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) associated with comorbidities such as hypertension, type 2 diabetes, or cardiovascular diseases. Treatment must be supervised by a physician, always in combination with a balanced diet and physical exercise, as part of a personalized weight loss plan. The use of tirzepatide requires a medical prescription and professional follow-up for dose adjustment and monitoring of effects.

Other health benefits

Besides weight loss, tirzepatide promotes metabolic improvements such as reduced blood pressure, improved cholesterol levels, lowered blood glucose, and increased insulin sensitivity. These effects help reduce cardiovascular risk and contribute to the remission of conditions like prediabetes and insulin resistance.